1. Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism.
- Author
-
Wang, Wenting, Yang, Lin, Song, Lei, Guo, Ming, Li, Changkun, Yang, Bin, Wang, Mingming, Kou, Na, Gao, Jie, Qu, Hua, Ma, Yan, Xue, Mei, and Shi, Dazhuo
- Subjects
- *
ASPIRIN , *ARACHIDONIC acid , *BLOOD platelets , *PANAX , *BLOOD platelet aggregation , *SAPONINS - Abstract
• High platelet reactivity and gastric mucosal injury after aspirin (ASA) treatment compromise clinical efficacy. • Adding Panax notoginseng saponin (PNS) to ASA potentiates platelet inhibition without increased bleeding. • PNS alleviates ASA-related dyspepsia symptoms and mitigates ASA-induced gastric mucosal injury. • These effects are associated with intraplatelet and gastric arachidonic acid metabolism modulation by lipidomic analysis. High platelet reactivity and gastric mucosal injury after aspirin (ASA) treatment are associated with poor compliance and an increased risk of cardiovascular events. Panax notoginseng saponins (PNS) have been widely used for the treatment of coronary heart disease (CHD) in addition to antiplatelet drugs in China; however, the joint effect and possible mechanism of PNS in addition to ASA on platelet activation and gastric injury remain unclear. This study was designed to investigate the combinational effects of PNS with ASA, and to explore the underlying mechanism via arachidonic acid (AA) metabolism pathway using lipidomic analysis. In a randomized, assessor-blinded trial, 42 patients with stable coronary heart disease (SCHD) and chronic gastritis were randomly assigned to receive ASA (n = 21) or PNS + ASA (n = 21) for 2 months. Compared with ASA alone, PNS + ASA further inhibited CD62p expression, GPIIb-IIIa activation and platelet aggregation and led to increased platelet inhibition rate. PNS + ASA suppressed the activity of platelet cyclooxygenase (COX)-1, and decreased the production of TXB 2 , PGD 2 , PGE 2 , 11-HETE, the downstream oxylipids of AA/COX-1 pathway in platelets, compared with ASA alone. The severity of dyspepsia assessment (SODA) results showed that patients in PNS + ASA group exhibited relieved dyspeptic symptoms as compared with those in ASA group, which might be associated with enhanced secretion of gastrin and motilin. In vivo study of myocardial infarction rats demonstrated that PNS attenuated ASA-induced gastric mucosal injury, which was related to markedly boosted gastric level of 6,15-diketo-13,14-dihydro-prostaglandin (PG)F1α, 13,14-dihydro-15-keto-PGE 2 and PGE 2 from AA/PG pathway in response to PNS + ASA compared with ASA alone. In summary, our study demonstrated that the combination of PNS and ASA potentiated the antiplatelet effect of ASA via AA/COX-1/TXB 2 pathway in platelets, and mitigated ASA-related gastric injury via AA/PG pathway in gastric mucosa. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF